When an outbreak begins, the first warning rarely comes from a hospital ward or a government press conference. It comes from a laboratory. A technician peers at a sample, a result flashes on a screen, and somewhere in the data, a pattern emerges that nobody wanted to see. That moment, a quiet, unglamorous, and largely invisible to the public is often the difference between an epidemic contained and a crisis out of control.
Public health laboratories are where samples from patients, water, food, animals, and the environment are tested to determine what is spreading, where it is going, and how fast it is moving. They are not simply diagnostic rooms. They are, in the truest sense, the country's early warning system. And in Pakistan, that system is under strain.
Most people, when they think of a lab, picture a hospital setting that run tests for a single patient, hand over results to a doctor, and treatment adjusted accordingly. A public health lab operates on an entirely different logic. It does not ask: what is wrong with this person? It asks: is this disease moving through the district? Are cases clustering in a particular neighbourhood? Is the same pathogen appearing in water sources across a province? Is what killed three children in one village connected to the illness reported in a market town fifty kilometres away? These are population-level questions, and they require population-level infrastructure. A hospital lab may save one life today. A functioning public health laboratory may prevent thousands of cases tomorrow.
When public health laboratories work well, the outbreaks they prevent never make the headlines – the epidemic that didn't happen leaves no trace in the public memory
The distinction matters enormously in a country like Pakistan, where health threats travel quickly through dense urban neighbourhoods, across livestock markets, along busy transport routes, and into rural communities where formal health services are already thin on the ground. Pakistan has seen, in recent years, both the value of functional public health laboratories and the cost of neglecting them. The neonatal mpox cluster identified in Sindh was confirmed through public health reference labs in Karachi, a case that required not just clinical observation but laboratory verification to understand what was happening and to trigger the right response. Without that confirmation, health authorities would have been responding to a mystery, not a known threat. In such instance, the laboratory network was either the asset that made rapid response possible, or the gap that let the outbreak gain ground before officials understood what they were facing.
Despite this record, public health laboratories in Pakistan remain chronically underfunded. The problems are not operational in nature rather than theoratical. Labs struggle to pay staff. Reagents run short. Equipment breaks down and is not repaired. Transport links between district collection points and provincial reference labs are unreliable, meaning samples arrive late, or not at all.
When detection slows, response slows. When response slows, outbreaks grow. It is a simple equation with devastating consequences.
Funding gaps also carry a less visible cost i.e., the erosion of expertise. Skilled laboratory scientists do not wait indefinitely for salaries or work indefinitely without functioning equipment. When they leave, they take years of training and institutional knowledge with them. Rebuilding that capacity takes far longer than the next outbreak is prepared to wait.
The economic argument for properly funded public health laboratories is straightforward, even if it is rarely made loudly enough. Early detection is cheaper than late response. The cost of identifying an outbreak in its first week, deploying a targeted response, and containing it within a UC or a town is a fraction of what it costs to manage a disease that has spread across multiple provinces, overwhelmed hospitals, and triggered a public panic. This is not a theoretical point. Countries that invested in laboratory infrastructure before Covid-19 hit mounted faster, more effective responses. Those that had neglected their systems scrambled and paid the price in lives and in economic disruption.
Pakistan needs permanent and dedicated budgetary allocations for public health laboratories, not occasional project grants that evaporate when donor priorities shift, but stable budget lines that allow labs to maintain trained staff, quality-assured equipment, functional supply chains, and reliable links to national and provincial surveillance networks.
Most Pakistanis will never visit a public health laboratory. Most will never know the name of the scientist who spotted the anomaly in the data, or the lab technician who ran the test that triggered an outbreak response in their city. That invisibility is, in a strange way, the point. When public health laboratories work well, the outbreaks they prevent never make the headlines. The epidemic that didn't happen leaves no trace in the public memory. But the infrastructure that stopped it is real, and it needs to be treated as what it is: essential national infrastructure, as fundamental to a functioning state as roads, schools, hospitals or power lines.
Pakistan cannot build a resilient health system on hospitals alone. It needs the labs that see the trouble coming, and the sustained political will to keep them ready before the next crisis arrives.